SCHWARTZ NORMAN D, CHAIR, CEO, reported a transaction classified as withholding at BIO-RAD LABORATORIES, INC. involving 2336.000000 shares for an estimated $889922.56. Reported holdings after the transaction were 446185.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chairman & CEO
Shares of Class A common stock acquired on the vesting of restricted stock units.
The reporting person disclaims beneficial ownership of these shares.
The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to th…
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
0 other filings
0 recent txs